Altre lingue Alpine Immune Sciences, Inc.

Azioni

ALPN

US02083G1004

Tempo differito Nasdaq Altri mercati azionari 22:00:00 17/05/2024			Variaz. 5gg	Var. 1 gen.
64,97 ^USD	+0,02%		-.--%	+240,87%

20/05	Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) ha completato l'acquisizione di Alpine Immune Sciences, Inc. (NasdaqGM:ALPN) da un gruppo di azionisti.	CI
10/05	L'accordo Alpine Immune Sciences, Vertex Pharmaceuticals supera un'altra pietra miliare	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from NASDAQ Composite Index	20/05
Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders.	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from S&P TMI Index	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from S&P Biotechnology Select Industry Index	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from S&P Global BMI Index	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from NASDAQ Biotechnology Index	17/05
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	10/05
Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Alpine Immune Sciences Reports First Quarter 2024 Financial Results	09/05
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	09/05
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug	06/05
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN	26/04
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN	18/04
North American Morning Briefing : Stock Futures -2-	17/04
North American Morning Briefing : Stock Futures -2-	15/04
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN	12/04
North American Morning Briefing : Big Banks Kick -2-	12/04
Wall Street termine en hausse	12/04
Health Care Slips on Risk Bias -- Health Care Roundup	11/04
POINT MARCHÉS-Wall Street termine en hausse	11/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Alpine Immune Sciences, Inc.

Azioni

ALPN

US02083G1004

Altre lingue

Filtri